These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31275543)

  • 1. Elevated Serum Homocysteine Levels Have Differential Gender-Specific Associations with Motor and Cognitive States in Parkinson's Disease.
    Bakeberg MC; Jefferson A; Riley M; Byrnes M; Ghosh S; Mastaglia FL; Horne MK; McGregor S; Stell R; Kenna J; Walters S; Hince D; Anderton RS
    Parkinsons Dis; 2019; 2019():3124295. PubMed ID: 31275543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson's Disease.
    Sleeman I; Lawson RA; Yarnall AJ; Duncan GW; Johnston F; Khoo TK; Burn DJ
    J Parkinsons Dis; 2019; 9(2):351-359. PubMed ID: 30909247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonlinear Relationship Between Homocysteine and Mild Cognitive Impairment in Early Parkinson's Disease: A Cross-Sectional Study.
    Ouyang Q; Xu L; Zhang Y; Huang L; Li L; Yu M
    Neuropsychiatr Dis Treat; 2024; 20():913-921. PubMed ID: 38707522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin B12 and Homocysteine Levels Predict Different Outcomes in Early Parkinson's Disease.
    Christine CW; Auinger P; Joslin A; Yelpaala Y; Green R;
    Mov Disord; 2018 May; 33(5):762-770. PubMed ID: 29508904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.
    Latourelle JC; Beste MT; Hadzi TC; Miller RE; Oppenheim JN; Valko MP; Wuest DM; Church BW; Khalil IG; Hayete B; Venuto CS
    Lancet Neurol; 2017 Nov; 16(11):908-916. PubMed ID: 28958801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Folate, Vitamin B12 Levels, and Systemic Immune-Inflammation Index Correlate With Motor Performance in Parkinson's Disease: A Cross-Sectional Study.
    Li S; Zhang Q; Gao Y; Nie K; Liang Y; Zhang Y; Wang L
    Front Neurol; 2021; 12():665075. PubMed ID: 34093411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: A meta-analysis.
    Xie Y; Feng H; Peng S; Xiao J; Zhang J
    Neurosci Lett; 2017 Jan; 636():190-195. PubMed ID: 27840145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Jarosz M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Sławek J
    Pharmacogenet Genomics; 2012 Oct; 22(10):716-24. PubMed ID: 22890010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of cardiovascular risk on disease progression in
    Oosterwegel MJ; Krijthe JH; den Brok MGHE; van den Heuvel L; Richard E; Heskes T; Bloem BR; Evers LJW
    Front Neurol; 2023; 14():1138546. PubMed ID: 37122316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Serum Homocysteine Level with Parkinson's Disease.
    Losy SA; Saiduzzman M; Battacharjee M; Moniruzzman AHM; Bhuya MSI; Linckon MK; Banerjee S; Islam MS; Mia E
    Mymensingh Med J; 2024 Jul; 33(3):643-648. PubMed ID: 38944701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum B12, Homocysteine Levels, and their Effect on Peripheral Neuropathy in Parkinson's Disease: Indian Cohort.
    Mathukumalli NL; Kandadai MR; Shaik JA; Kanikannan MA; Borgohain R
    Ann Indian Acad Neurol; 2020; 23(1):48-53. PubMed ID: 32055122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of serum levels of homocysteine, vitamin B12 and folate to cognitive functions in multiple sclerosis patients.
    Fahmy EM; Elfayoumy NM; Abdelalim AM; Sharaf SA; Ismail RS; Elshebawy H
    Int J Neurosci; 2018 Sep; 128(9):835-841. PubMed ID: 29384421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
    An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
    J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated HDL Levels Linked to Poorer Cognitive Ability in Females With Parkinson's Disease.
    Bakeberg MC; Gorecki AM; Kenna JE; Jefferson A; Byrnes M; Ghosh S; Horne MK; McGregor S; Stell R; Walters S; Mastaglia FL; Anderton RS
    Front Aging Neurosci; 2021; 13():656623. PubMed ID: 34177552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma homocysteine levels in patients treated with levodopa: motor and cognitive associations.
    Ozer F; Meral H; Hanoglu L; Aydemir T; Yilsen M; Cetin S; Ozturk O; Seval H; Koldas M
    Neurol Res; 2006 Dec; 28(8):853-8. PubMed ID: 17288745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
    Regnault A; Boroojerdi B; Meunier J; Bani M; Morel T; Cano S
    J Neurol; 2019 Aug; 266(8):1927-1936. PubMed ID: 31073716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Uric Acid in LRRK2 Related Parkinson's Disease: Longitudinal Data from the PPMI Study.
    Bougea A; Koros C; Papagiannakis N; Simitsi AM; Prentakis A; Papadimitriou D; Pachi I; Antonelou R; Angelopoulou E; Beratis I; Bozi M; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
    J Parkinsons Dis; 2021; 11(2):633-640. PubMed ID: 33682725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of vitamin B12, folate, and entacapone on homocysteine levels in levodopa-treated Parkinson's disease patients: A randomized controlled study.
    Anamnart C; Kitjarak R
    J Clin Neurosci; 2021 Jun; 88():226-231. PubMed ID: 33992189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma homocysteine, folate and vitamin B12 levels in Parkinson's disease in China: A meta-analysis.
    Dong B; Wu R
    Clin Neurol Neurosurg; 2020 Jan; 188():105587. PubMed ID: 31733593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocysteinemia in patients with Parkinson's disease and relationship to vitamin B level.
    Shin HW; Sohn YH
    J Mov Disord; 2009 May; 2(1):33-6. PubMed ID: 24868350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.